11 employees
resTORbio is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics.
2016
$40M
from 3 investors over 3 rounds
resTORbio raised $40M on November 30, 2017
Investors: Quan Capital 泉创资本 and OrbiMed Advisors
resTORbio raised $25M on January 1, 2017
Investors: PureTech Health